Navigation Links
Journal of Vascular and Interventional Radiology sees growth, promise of tumor ablation
Date:8/26/2010

FAIRFAX, Va.The unprecedented growth and promise of using thermal ablation to target and kill cancer is the subject of the Journal of Vascular and Interventional Radiology's August supplement, "Thermal Ablation 2010: At the Crossroads of Past Success, Current Goals and Future Technology."

"The Journal of Vascular and Interventional Radiology supplement sheds light on the development of multiple medical techniques and devices for cancer tumor ablation," said Daniel B. Brown, M.D., guest editor. "For all its richness of information, the JVIR supplement should be considered a snapshot of the state of the art," added Brown, an interventional radiologist and chief of interventional radiology and interventional oncology at Thomas Jefferson University Hospital in Philadelphia, Pa. The supplement articles provide a current overview of the types of ablation devices that are commonly used and are now expanding in clinical practice and review the current status of ablation outcomes in different organ systems.

"As interventional oncology continues to grow over the next few years, additional advances will be made within existing and novel treatments, including liquid nitrogen-based cryotherapy, newer microwave devices, magnetic resonance-guided focused ultrasound and other technologies," said Brown.

"Interventional radiologists and other practitioners interested in tumor ablation currently face a number of challenging questions: What patients are best served by ablation? What results can be anticipated? Can ablation be combined with other types of tumor therapy to improve outcomes?" said JVIR editor Albert A. Nemcek Jr., M.D., FSIR. "This supplement helps answer those questions," said Nemcek, an interventional radiologist and professor of radiology and surgery at Northwestern Memorial Hospital in Chicago, Ill.

The following articles are included in "Thermal Ablation 2010: At the Crossroads of Past Success, Current Goals and Future Technology."

  • "Radiofrequency Ablation: Mechanism of Action and Devices"
  • "Cryoablation: Mechanism of Action and Devices"
  • "Microwave Tumor Ablation: Mechanism of Action, Clinical Results and Devices"
  • "Percutaneous Ablation of Hepatocellular Carcinoma: Current Status"
  • "Ablation of Liver Metastases: Current Status"
  • "Ablation of Pulmonary Malignancy: Current Status"
  • "Thermal Ablation of Renal Cell Carcinoma: Triage, Treatment and Follow-up"
  • "Ablation of Skeletal Metastases: Current Status"
  • "Enhancing Ablation: Synergies With Regional and Systemic Therapies"
  • "Navigation Systems for Ablation"


'/>"/>

Contact: Maryann Verrillo
mverrillo@fsirweb.org
703-460-5572
Society of Interventional Radiology
Source:Eurekalert

Related medicine news :

1. Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
2. New impact factor of European Urology underlines journals outstanding position
3. JDR increases its 5-Year SIF and remains number one dental journal of 64 in its category
4. San Antonio Business Journal Names BMI of Texas One of the Best Places to Work in San Antonio
5. Capital Confirmation Named Best In Business by Nashville Business Journal
6. Study Published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association Shows Algal DHA Improved Memory and Learning in Healthy Adults Age 55 and Older
7. Journal editors call for standards in comparative effectiveness research
8. The American Society for Aesthetic Plastic Surgery (ASAPS) Announces the 2010 Journalistic Achievement Award Winners
9. Dr. Khanna Featured in the San Fernando Business Journal
10. Travel Medicine becomes the official journal of RCPSGs Faculty of Travel Medicine
11. AERA journal examines research issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... office, will speak at the American Conference Institute’s 21st Drug & Medical Device ... a Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical ...
(Date:12/2/2016)... ... 2016 , ... Advanced Inc., a leading provider of travel therapy and travel ... serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served ... and operational leadership experience to Advanced Inc. He began his career in finance at ...
(Date:12/2/2016)... PITTSBURGH, PA (PRWEB) , ... December 02, 2016 , ... ... or struggling through rehabilitation of an injury, patients must find the one that works ... for his pain, he created a machine that worked and decided to share it ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and ... storing, shipping and disposal. The new version is a faster and a more ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... YORK , December 2, 2016 ... 5,251.11, down 1.36%; the Dow Jones Industrial Average edged 0.36% ... at 2,191.08, down 0.35%. Losses were broad based as six ... Stock-Callers.com has initiated research reports on the following Services equities: ... (NASDAQ: QGEN ), INC Research Holdings Inc. (NASDAQ: ...
(Date:12/2/2016)... , Dec. 1, 2016 Around the ... country, region and each habitable land present over earth. ... every individual once in a life time this is ... care available until now. Given the steady increase in ... together with the spiraling healthcare costs of treatment, there ...
(Date:12/2/2016)... The iShares Nasdaq Biotechnology Exchange-Traded Fund ... victory early in November. Less political risk has boosted ... predicting an uptick in M&A activities. Today, Stock-Callers.com takes ... they have fared at the last close: Celldex Therapeutics ... (NASDAQ: FOLD ), Navidea Biopharmaceuticals Inc. (NYSE ...
Breaking Medicine Technology: